GlassScriptPhysician profile
Karen Paz
NPI 1023254240
$14,801.76
in general payments reported to CMS, 2019-2025
68 companies · $3,812 in 2025
The $3,812 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $53.71 · 2022: $2,385 · 2023: $4,194 · 2024: $4,357 · 2025: $3,812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,072.09 |
| Education | $290.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,088.33 | 2022-2025 | Keytruda, Welireg, Lynparza |
| Novartis Pharmaceuticals Corporation | $1,041.74 | 2022-2025 | Piqray, Kisqali |
| Astrazeneca Pharmaceuticals LP | $1,023.98 | 2022-2025 | Enhertu, Imfinzi, Lynparza |
| Pfizer INC. | $872.49 | 2022-2025 | |
| Janssen Biotech, INC. | $835.12 | 2021-2025 | Darzalex, Tecvayli, Carvykti |
| Incyte Corporation | $628.49 | 2022-2025 | Jakafi, Monjuvi, Pemazyre |
| Celgene Corporation | $598.44 | 2022-2025 | Reblozyl, Pomalyst, Opdualag |
| Abbvie INC. | $544.44 | 2023-2025 | |
| Daiichi Sankyo INC. | $465.63 | 2022-2025 | Enhertu, Injectafer, Vanflyta |
| Seagen INC. | $453.77 | 2022-2023 | Adcetris, Tukysa, Padcev |
| Lilly USA, LLC | $415.01 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Takeda Pharmaceuticals U.S.A., INC. | $367.62 | 2022-2025 | Fruzaqla, Ninlaro, Iclusig |
| Bayer Healthcare Pharmaceuticals INC. | $305.07 | 2022-2025 | |
| Astellas Pharma US INC | $297.37 | 2022-2025 | Xtandi, Vyloy, Padcev |
| Eisai INC. | $289.87 | 2022-2025 |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $271.00 | 2023-2025 | |
| Array Biopharma INC | $260.07 | 2022-2025 | Braftovi, Mektovi, Lorbrena |
| E.R. Squibb & Sons, L.L.C. | $259.04 | 2022-2025 | Augtyro, Opdivo |
| Emd Serono, INC. | $233.56 | 2022-2025 | Tepmetko, Bavencio |
| Genzyme Corporation | $231.93 | 2022-2025 | |
| Amgen INC. | $231.30 | 2023 | Kyprolis, Lumakras |
| Sobi, INC | $218.97 | 2023-2025 | |
| Genentech USA, INC. | $209.18 | 2022-2024 | Lunsumio, Polivy, Columvi |
| Regeneron Healthcare Solutions, INC. | $207.65 | 2022-2025 | Libtayo |
| Mirati Therapeutics, INC. | $199.46 | 2023-2024 | Krazati |
| Karyopharm Therapeutics INC. | $178.66 | 2022-2025 | Xpovio |
| Exelixis INC. | $156.46 | 2022-2025 | Cabometyx |
| Pharmacyclics LLC, An Abbvie Company | $155.58 | 2022-2023 | Imbruvica, Epkinly |
| Pharmacosmos Therapeutics INC. | $151.83 | 2022-2025 | Monoferric, Cosela |
| Ipsen Biopharmaceuticals, INC | $149.56 | 2022-2025 | Onivyde, Somatuline Depot, Tazverik |
| Puma Biotechnology, INC. | $148.55 | 2022-2025 | |
| Gilead Sciences, INC. | $147.77 | 2022-2025 | Trodelvy |
| Alexion Pharmaceuticals, INC. | $136.08 | 2023-2025 | Ultomiris |
| Taiho Oncology, INC. | $133.67 | 2023-2025 | |
| Horizon Therapeutics Plc | $125.00 | 2022 | |
| Stemline Therapeutics INC. | $116.83 | 2023-2025 | Orserdu |
| Jazz Pharmaceuticals INC. | $116.30 | 2022-2025 | |
| Pharmaessentia USA Corporation | $106.60 | 2022-2025 | Besremi |
| Agios Pharmaceuticals, INC. | $100.94 | 2023-2025 | Pyrukynd |
| Sumitomo Pharma America, INC. | $97.76 | 2023-2025 | Orgovyx |
| Beone Medicines USA, INC. | $90.95 | 2025 | Brukinsa |
| Genmab U.S., INC. | $90.45 | 2024-2025 | Epkinly |
| G1 Therapeutics, INC. | $83.69 | 2022-2023 | Cosela |
| Alnylam Pharmaceuticals INC. | $82.53 | 2023-2024 | Givlaari |
| Tersera Therapeutics LLC | $81.05 | 2023-2025 | Zoladex |
| Adc Therapeutics America, INC. | $79.14 | 2024-2025 | |
| Beigene USA, INC. | $73.30 | 2023-2024 | Brukinsa |
| Deciphera Pharmaceuticals INC. | $70.15 | 2024-2025 | Qinlock, Romvimza, Tgct |
| Aveo Pharmaceuticals, INC. | $46.61 | 2022-2025 | |
| Geron Corporation | $45.87 | 2025 | Rytelo |
| Amneal Pharmaceuticals LLC | $43.90 | 2025 | Alymsys |
| Springworks Therapeutics, INC. | $40.97 | 2024-2025 | Ogsiveo |
| Recordati_rare_diseases_inc. | $39.69 | 2025 | Enjaymo, Sylvant |
| Glaxosmithkline, LLC. | $36.67 | 2023-2025 | Zejula, Jemperli |
| Caris Mpi, INC. | $34.62 | 2025 | Mi Cancer Seek |
| Heron Therapeutics, INC. | $34.05 | 2022-2023 | Cinvanti |
| Legend Biotech USA INC. | $28.99 | 2024 | |
| Verity Pharmaceuticals INC. | $28.50 | 2023-2024 | Trelstar |
| Dendreon Pharmaceuticals LLC | $27.35 | 2025 | Provenge |
| Adaptive Biotechnologies Corporation | $24.64 | 2023 | Clonoseq |
| Kyowa Kirin, INC. | $22.21 | 2023 | Poteligeo |
| Fennec Pharmaceuticals, INC. | $21.11 | 2025 | Fyarro |
| Accord Healthcare, INC. | $20.28 | 2023 | |
| Tempus Ai, INC | $18.88 | 2025 | Xt Cdx |
| Digestive Care, INC. | $18.58 | 2025 | Pertzye |
| Eusa Pharma (US) LLC | $18.51 | 2022 | |
| Syndax Pharmaceuticals, INC. | $17.64 | 2025 | |
| Organon LLC | $10.31 | 2022 |
Drugs and devices associated with these payments
Keytruda $842Enhertu $433Kisqali $382Jaypirca $373Imbruvica $371Reblozyl $364Lynparza $332Jakafi $331Darzalex $322Adcetris $300Orgovyx $276Xtandi $265Tecvayli $261Lenvima $257Welireg $254Verzenio $249Epkinly $233Padcev $221Braftovi $213Pluvicto $209Krazati $199Mektovi $192Elrexfio $191Venclexta $190Libtayo $188Tukysa $185Nubeqa $184Piqray $181Tibsovo $174Vonjo $169Brukinsa $164Fruzaqla $161Elahere $161Lorbrena $160Xpovio $160Pomalyst $157Kyprolis $153Imfinzi $148Bosulif $137Ultomiris $136Inqovi $134Lonsurf $134Cabometyx $133Retevmo $126Augtyro $124Carvykti $124Monjuvi $123Sarclisa $123Orserdu $117Monoferric $115Vitrakvi $115Stivarga $115Talvey $108Talzenna $105Opdivo $105Onivyde $104Rybrevant $92.45Scemblix $87.51Injectafer $85.42Besremi $82.82Givlaari $82.53Zoladex $81.05Lumakras $78.70Cosela $78.43Fabhalta $76.21Pertzye $74.32Comirnaty $72.88Paxlovid $72.66Pemazyre $72.25Pyrukynd $70.81Zepzelca $70.37Qinlock $70.15Vyloy $67.91Ninlaro $67.59Besponsa $63.21Iclusig $60.69Zynlonta $59.77Vanflyta $56.83Lutathera $53.72Zynyz $50.94Doptelet $49.73Ibrance $46.98Voranigo $46.84Promacta $46.16Rytelo $45.87Erleada $45.45Balversa $45.45Inlyta $44.94Alymsys $43.90Ogsiveo $40.97Columvi $40.25Polivy $40.25Lunsumio $40.25Nerlynx $39.83Zejula $36.67Tasigna $34.65Mi Cancer Seek $34.62Xospata $30.46Datroway $28.69Trelstar $28.50
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Paz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.